Smith Graham & Co Investment Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$8.01M	Sell	130,887 -808	-0.6%	-$48K	0.92%	31
2023 Q3	$7.53M	Sell	131,695 -10,972	-8%	-$663K	0.94%	31
2023 Q2	$8.48M	Sell	142,667 -6,368	-4%	-$381K	1.03%	28
2023 Q1	$9.33M	Sell	149,035 -470	-0.3%	-$29.3K	1.13%	14
2022 Q4	$9.36M	Sell	149,505 -517	-0.3%	-$29.6K	1.15%	16
2022 Q3	$7.48M	Sell	150,022 -208	-0.1%	-$11.5K	0.99%	26
2022 Q2	$8.83M	Sell	150,230 -1,527	-1%	-$84.2K	1.09%	19
2022 Q1	$8.03M	Sell	151,757 -986	-0.6%	-$56.9K	0.83%	46
2021 Q4	$9.26M	Sell	152,743 -12,454	-8%	-$739K	0.92%	34
2021 Q3	$9.27M	Sell	165,197 -14,238	-8%	-$782K	0.93%	35
2021 Q2	$9.35M	Sell	179,435 -22,727	-11%	-$1.09M	0.83%	45
2021 Q1	$8.91M	Buy	+202,162	New	+$8.49M	0.72%	54

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Smith Graham & Co Investment Advisors's PBH Position: Q4 2023 in Review

Smith Graham & Co Investment Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 0.61% in Q4 2023, selling an estimated $48K and leaving 130,887 shares worth $8.01M. The position accounts for 0.92% of the portfolio, ranked #31.

Smith Graham & Co Investment Advisors first reported a position in PBH in Q1 2021 and has held it in 12 quarters since. The position peaked at $9.36M in Q4 2022. 288 funds tracked by Wall St. Rank hold PBH as of Q4 2023.

Smith Graham & Co Investment Advisors held 130,887 shares of Prestige Consumer Healthcare worth $8.01M as of Q4 2023.
Smith Graham & Co Investment Advisors sold 808 Prestige Consumer Healthcare shares in Q4 2023, an estimated $48K.
Prestige Consumer Healthcare made up 0.92% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #31 holding.
Smith Graham & Co Investment Advisors first reported a position in Prestige Consumer Healthcare in Q1 2021 and has held it in 12 quarters since.
Smith Graham & Co Investment Advisors's Prestige Consumer Healthcare position peaked at $9.36M in Q4 2022.
288 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2023.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.